コンテンツへスキップ
Merck
  • Successful oral therapy for severe falciparum malaria: the World Health Organization criteria revisited.

Successful oral therapy for severe falciparum malaria: the World Health Organization criteria revisited.

The American journal of tropical medicine and hygiene (2012-03-10)
Eran Kopel, Enbal Marhoom, Yechezkel Sidi, Eli Schwartz
要旨

We report a successful treatment of severe falciparum malaria in a non-immune adult patient with 30% parasitemia treated with the 6-dose oral regimen of artemether plus lumefantrine combination therapy alone. We have also retrospectively searched our tertiary center's database for similar cases and we have found two additional severe malaria cases, resolved uneventfully with oral regimen. These cases might indicate a need to specifically address the definition of severe and complicated malaria in non-immune patients either in designated guidelines or as an explicit addition to the historical World Health Organization criteria.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
アーテメーター, ≥98% (HPLC)
Sigma-Aldrich
ルメファントリン